About 230K results
Open links in new tab
News Details - novonordisk.com
Novo Nordisk A/S: Monlunabant phase 2a trial in obesity …
Novo Nordisk's Monlunabant Data Drags Stocks Of Smaller Players
Novo Nordisk Stock Declines After Headline Results From Mid …
Novo Nordisk (NVO): Monlunabant phase 2a trial in obesity …
Novo Nordisk’s obesity newcomer monlunabant heads into …
Novo Nordisk shares drop nearly 5% on disappointing obesity pill …
Novo Nordisk Slips On Phase 2a Clinical Trial Result With Monlunabant
Novo Nordisk's experimental weight loss pill has some ... - Yahoo
Novo Nordisk A/S: Monlunabant phase 2a trial in obesity …
- Some results have been removed